We are live on ! Find out more
BG

Bahl & Gaynor Portfolio holdings

AUM $19.8B
1-Year Est. Return 19.53%
This Fund
S&P 500
This Quarter Est. Return
-0.12%
1 Year Est. Return
+19.53%
3 Year Est. Return
+63.97%
5 Year Est. Return
+84.2%
10 Year Est. Return
+296.44%
AUM
$6.71B
AUM Growth
+$133M
Cap. Flow
+$178M
Cap. Flow %
2.66%
Top 10 Hldgs %
26.7%
Holding
442
New
38
Increased
200
Reduced
128
Closed
18

Top Buys

Rank Stock Value
1
MMM icon
3M
MMM
+$44.9M
2
HSY icon
Hershey
HSY
+$33.9M
3
VTR icon
Ventas
VTR
+$33.1M
4
PAYX icon
Paychex
PAYX
+$31M
5
PEP icon
PepsiCo
PEP
+$26.1M

Top Sells

Rank Stock Value
1
GSK icon
GSK
GSK
+$54.8M
2
AAPL icon
Apple
AAPL
+$24M
3
O icon
Realty Income
O
+$21.6M
4
CFR icon
Cullen/Frost Bankers
CFR
+$17.6M
5
IBM icon
IBM
IBM
+$8.55M

Sector Composition

Rank Sector Weight
1 Healthcare 16.26%
2 Consumer Staples 15.49%
3 Technology 15.18%
4 Industrials 11.77%
5 Energy 10.06%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BRK.B icon
101
Berkshire Hathaway Class B
BRK.B
$1.11T
$7.29M 0.11%
52,748
-2,020
-4% -$269K
TRGP icon
102
Targa Resources
TRGP
$56.6B
$6.98M 0.1%
51,276
+1,258
+3% +$173K
HCSG icon
103
Healthcare Services Group
HCSG
$1.6B
$6.88M 0.1%
240,682
+7,874
+3% +$219K
TFX icon
104
Teleflex
TFX
$6.18B
$6.68M 0.1%
63,615
SIAL
105
DELISTED
SIGMA - ALDRICH CORP
SIAL
$6.51M 0.1%
47,853
-6,654
-12% -$707K
RDS.A
106
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
$6.39M 0.1%
83,982
-5,850
-7% -$470K
RMD icon
107
ResMed
RMD
$32.1B
$6.12M 0.09%
124,263
+4,220
+4% +$215K
SNI
108
DELISTED
Scripps Networks Interactive, Inc Common Class A
SNI
$5.78M 0.09%
74,052
+2,080
+3% +$168K
O icon
109
Realty Income
O
$58.7B
$5.19M 0.08%
131,416
-507,450
-79% -$21.6M
FITB
110
Fifth Third Bancorp
FITB
$52.8B
$5.09M 0.08%
254,436
-2,663
-1% -$54.7K
IYW icon
111
iShares US Technology ETF
IYW
$25.2B
$5.08M 0.08%
201,800
-160
-0.1% -$4K
MKTX icon
112
MarketAxess Holdings
MKTX
$5.71B
$4.88M 0.07%
78,853
+10,405
+15% +$586K
FISV
113
Fiserv Inc
FISV
$29.3B
$4.8M 0.07%
148,560
+900
+0.6% +$28.4K
FAST icon
114
Fastenal
FAST
$56.7B
$4.49M 0.07%
400,104
-1,500
-0.4% -$17.1K
OKS
115
DELISTED
Oneok Partners LP
OKS
$4.46M 0.07%
79,732
+1,000
+1% +$57K
VWO icon
116
Vanguard FTSE Emerging Markets ETF
VWO
$123B
$4.32M 0.06%
103,542
-130
-0.1% -$5.77K
GNTX icon
117
Gentex
GNTX
$5.1B
$4.23M 0.06%
316,134
+51,130
+19% +$744K
BCPC
118
Balchem Corp
BCPC
$5.62B
$4.21M 0.06%
74,420
+1,435
+2% +$76.4K
ARG
119
DELISTED
Airgas Inc
ARG
$4.19M 0.06%
37,887
-1,315
-3% -$144K
DUK icon
120
Duke Energy
DUK
$97.2B
$4.17M 0.06%
55,834
+1,503
+3% +$110K
BRK.A icon
121
Berkshire Hathaway Class A
BRK.A
$1.11T
$4.14M 0.06%
20
+2
+11% +$400K
BNS icon
122
Scotiabank
BNS
$106B
$4.08M 0.06%
70,466
+1,013
+1% +$63.1K
LOW icon
123
Lowe's Companies
LOW
$122B
$3.75M 0.06%
70,901
-4,231
-6% -$214K
PSX icon
124
Phillips 66
PSX
$82.5B
$3.74M 0.06%
45,959
-338
-0.7% -$28.1K
CL icon
125
Colgate-Palmolive
CL
$73.3B
$3.7M 0.06%
56,759
+6,080
+12% +$401K

Similar funds

Bahl & Gaynor's Q3 2014 Portfolio in Review

As of Q3 2014, Bahl & Gaynor held 442 positions worth $6.71B, up 2% from $6.58B the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Bahl & Gaynor's Q3 2014 filing shows 38 new, 200 increased, 128 reduced and 18 closed positions. Its largest new stake was Cracker Barrel: 9,775 shares worth $1.01M. The largest sale was GSK, an estimated $54.8M.

By sector, the portfolio is most concentrated in Healthcare at 16% of assets, down from 17% a quarter earlier, followed by Consumer Staples and Technology.

  • Bahl & Gaynor's largest Q3 2014 buy was Cracker Barrel: 9,775 shares worth $1.01M.
  • Bahl & Gaynor added most to 3M in Q3 2014, an estimated $44.9M increase.
  • Bahl & Gaynor's biggest Q3 2014 reduction was GSK, cutting an estimated $54.8M.
  • Bahl & Gaynor fully exited GNC Holdings, Inc. in Q3 2014, selling an estimated $2.07M.
  • Bahl & Gaynor's ten largest holdings make up 27% of its $6.71B portfolio in Q3 2014.
  • Bahl & Gaynor opened 38 new positions and closed 18 in Q3 2014.
  • Bahl & Gaynor's portfolio value rose 2% quarter-over-quarter to $6.71B.

Based on Bahl & Gaynor's 13F filing for Q3 2014, filed 12 Nov 2014.